APOBEC1 and pancreatic adenocarcinoma: In summary, these results show that APOBEC1/3A/3G/3H is generally upregulated in PAAD, and the high expression levels of APOBEC1/3A/3G/3H are related to the poor clinicopathological features and prognosis of PAAD patients.